The stock's rise snapped a four-day losing streak.

Cramer looks at Illumina, Archer Aviation, NANO Nuclear Energy, Steris, Sixth Street Specialty Lending, Lam Research and ...

Illumina stock skidded Tuesday after China signaled it would ban the company from importing its gene-mapping products.

RBC Capital lowered the firm’s price target on Illumina (ILMN) to $128 from $247 but keeps an Outperform rating on the shares. The company’s ...

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Jazz Pharmaceuticals (JAZZ) and Illumina (ILMN). But which of these two stocks is more attractive to value ...

The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.

Illumina slashes costs by $100 million after China bans its sequencers. The company lowers its 2025 EPS outlook and aims for ...

In a report released yesterday, Conor McNamara from RBC Capital maintained a Buy rating on Illumina (ILMN – Research Report), with a price ...

Illumina shareholders received a warning shot. In response to President Trump’s initial tariff measures, the Chinese ...

What a brutal six months it’s been for Illumina. The stock has dropped 30.9% and now trades at $84.65, rattling many shareholders. This may have investors wondering how to approach the situation.

The stock's fall snapped a two-day winning streak.

Illumina on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ban ...